Aiming to expedite drug development, enhance the body of clinical evidence supporting new and existing therapies, and improve ...

The PARKEO2 trial, registered under ClinicalTrials.gov identifier NCT04884412, holds the promise of enhancing surgical outcomes for Parkinson's disease, offering a path to more effective and ...

Clinical trials sponsored by Big Pharma enrolled eight times as many patients as U.S.-government trials did between 20 ...

Dr. Clifford Yut shares how Houstonians can participate in clinical research and groundbreaking clinical trials.

Research shows that between 2018 and 2022, industry-sponsored trials enrolled over eight times more patients than federally ...

Cheong points to the broad spectrum of patient demographics in the APAC region for creating substantial opportunities for clinical trial sponsors who are keen to meet enrolment targets at an expedited ...

MediciNova holds Orphan Drug Designation for MN-166 (ibudilast) in ALS by U.S. FDA and EU EMA. MN-166 (ibudilast) has received Fast Track Designation by FDA for treatment of ALS. In addition, MN-166 ...

NIA Alzheimer's Trials While $3.5 billion are spent annually in the U.S. on federally sponsored Alzheimer's research, only two disease-modifying treatments -- lecanemab (Leqembi) and aducanumab ...

Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in pharmaceutical industry ...

Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients ...

Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in pharmaceutical industry ...

A clinical trial involves the study of the safety, efficacy and/or dosage regimen of a therapeutic intervention (such as a drug) in humans selected according to predetermined criteria of ...